Long	long	O	O	O	O
term	term	O	O	O	O
audiological	audiological	O	O	O	O
evaluation	evaluation	O	O	O	O
of	of	O	O	O	O
beta-thalassemic	beta-thalassemic	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

OBJECTIVE	objective	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
objective	objective	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
was	was	O	O	O	O
to	to	O	O	O	O
identify	identify	O	O	O	O
the	the	O	O	O	O
incidence	incidence	O	O	O	O
and	and	O	O	O	O
to	to	O	O	O	O
monitor	monitor	O	O	O	O
the	the	O	O	O	O
progression	progression	O	O	O	O
of	of	O	O	O	O
hearing	hearing	O	DISEASE	OTHERS	I
loss	loss	O	DISEASE	OTHERS	I
in	in	O	O	O	O
children	children	O	O	O	O
and	and	O	O	O	O
young	young	O	O	O	O
adults	adults	O	O	O	O
with	with	O	O	O	O
beta-thalassemia	beta-thalassemia	O	O	O	O
major	major	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
One	one	O	O	O	O
hundred	hundred	O	O	O	O
and	and	O	O	O	O
four	four	O	O	O	O
(	(	O	O	O	O
104	104	O	O	O	O
)	)	O	O	O	O
patients	patients	O	O	O	O
aged	aged	O	O	O	O
6	6	O	O	O	O
-	-	O	O	O	O
35	35	O	O	O	O
years	years	O	O	O	O
(	(	O	O	O	O
mean	mean	O	O	O	O
17,2	17,2	O	O	O	O
years	years	O	O	O	O
)	)	O	O	O	O
participated	participated	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

All	all	O	O	O	O
patients	patients	O	O	O	O
were	were	O	O	O	O
on	on	O	O	O	O
a	a	O	O	O	O
regular	regular	O	O	O	O
transfusion-chelation	transfusion-chelation	O	O	O	O
program	program	O	O	O	O
maintaining	maintaining	O	O	O	O
a	a	O	O	O	O
mean	mean	O	O	O	O
hemoglobin	hemoglobin	O	O	O	O
level	level	O	O	O	O
of	of	O	O	O	O
9.5	9.5	O	O	O	O
gr/dl	gr/dl	O	O	O	O
.	.	O	O	O	O

Subjects	subjects	O	O	O	O
were	were	O	O	O	O
receiving	receiving	O	O	O	O
desferrioxamine	desferrioxamine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
DFO	dfo	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
chelation	chelation	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
mean	mean	O	O	O	O
daily	daily	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
50	50	O	O	O	O
-	-	O	O	O	O
60	60	O	O	O	O
mg/kg	mg/kg	O	O	O	O
,	,	O	O	O	O
5	5	O	O	O	O
-	-	O	O	O	O
6	6	O	O	O	O
days	days	O	O	O	O
a	a	O	O	O	O
week	week	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
six	six	O	O	O	O
years	years	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
which	which	O	O	O	O
was	was	O	O	O	O
then	then	O	O	O	O
reduced	reduced	O	O	O	O
to	to	O	O	O	O
40	40	O	O	O	O
-	-	O	O	O	O
50	50	O	O	O	O
mg/kg	mg/kg	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
following	following	O	O	O	O
eight	eight	O	O	O	O
years	years	O	O	O	O
.	.	O	O	O	O

Patients	patients	O	O	O	O
were	were	O	O	O	O
followed	followed	O	O	O	O
for	for	O	O	O	O
8	8	O	O	O	O
-	-	O	O	O	O
14	14	O	O	O	O
years	years	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
Overall	overall	O	O	O	O
,	,	O	O	O	O
21	21	O	O	O	O
out	out	O	O	O	O
of	of	O	O	O	O
104	104	O	O	O	O
patients	patients	O	O	O	O
(	(	O	O	O	O
20.2	20.2	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
presented	presented	O	O	O	O
with	with	O	O	O	O
high	high	O	O	O	O
frequency	frequency	O	O	O	O
sensorineural	sensorineural	O	DISEASE	OTHERS	I
hearing	hearing	O	DISEASE	OTHERS	I
loss	loss	O	DISEASE	OTHERS	I
(	(	O	O	O	O
SNHL	snhl	O	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
either	either	O	O	O	O
unilateral	unilateral	O	O	O	O
or	or	O	O	O	O
bilateral	bilateral	O	O	O	O
.	.	O	O	O	O

No	no	O	O	O	O
ototoxic	ototoxic	O	O	OTHERS	I
factor	factor	O	O	O	O
,	,	O	O	O	O
other	other	O	O	O	O
than	than	O	O	O	O
DFO	dfo	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
was	was	O	O	O	O
present	present	O	O	O	O
in	in	O	O	O	O
any	any	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

Patients	patients	O	O	O	O
with	with	O	O	O	O
SNHL	snhl	O	O	OTHERS	I
presented	presented	O	O	O	O
with	with	O	O	O	O
relatively	relatively	O	O	O	O
lower	lower	O	O	O	O
serum	serum	O	O	O	O
ferritin	ferritin	O	O	O	O
levels	levels	O	O	O	O
than	than	O	O	O	O
those	those	O	O	O	O
with	with	O	O	O	O
normal	normal	O	O	O	O
hearing	hearing	O	O	O	O
,	,	O	O	O	O
however	however	O	O	O	O
,	,	O	O	O	O
no	no	O	O	O	O
statistically	statistically	O	O	O	O
significant	significant	O	O	O	O
difference	difference	O	O	O	O
was	was	O	O	O	O
observed	observed	O	O	O	O
.	.	O	O	O	O

Subjects	subjects	O	O	O	O
with	with	O	O	O	O
SNHL	snhl	O	O	OTHERS	I
were	were	O	O	O	O
submitted	submitted	O	O	O	O
to	to	O	O	O	O
DFO	dfo	CHEMICALS	O	OTHERS	I
reduction	reduction	O	O	O	O
or	or	O	O	O	O
temporary	temporary	O	O	O	O
withdrawal	withdrawal	O	O	O	O
.	.	O	O	O	O

Following	following	O	O	O	O
intervention	intervention	O	O	O	O
,	,	O	O	O	O
7	7	O	O	O	O
out	out	O	O	O	O
of	of	O	O	O	O
21	21	O	O	O	O
affected	affected	O	O	O	O
patients	patients	O	O	O	O
recovered	recovered	O	O	O	O
,	,	O	O	O	O
10	10	O	O	O	O
remained	remained	O	O	O	O
stable	stable	O	O	O	O
and	and	O	O	O	O
4	4	O	O	O	O
demonstrated	demonstrated	O	O	O	O
aggravation	aggravation	O	O	O	O
.	.	O	O	O	O

CONCLUSION	conclusion	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
findings	findings	O	O	O	O
are	are	O	O	O	O
indicative	indicative	O	O	O	O
of	of	O	O	O	O
DFO	dfo	CHEMICALS	O	OTHERS	I
's	's	O	O	O	O
contributing	contributing	O	O	O	O
role	role	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
development	development	O	O	O	O
of	of	O	O	O	O
hearing	hearing	O	DISEASE	OTHERS	I
impairment	impairment	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Regular	regular	O	O	O	O
audiologic	audiologic	O	O	O	O
evaluation	evaluation	O	O	O	O
is	is	O	O	O	O
imperative	imperative	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
thalassemic	thalassemic	O	O	OTHERS	I
patients	patients	O	O	O	O
so	so	O	O	O	O
that	that	O	O	O	O
early	early	O	O	O	O
changes	changes	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
recognized	recognized	O	O	O	O
and	and	O	O	O	O
treatment	treatment	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
judiciously	judiciously	O	O	O	O
adjusted	adjusted	O	O	O	O
in	in	O	O	O	O
order	order	O	O	O	O
to	to	O	O	O	O
prevent	prevent	O	O	O	O
or	or	O	O	O	O
reverse	reverse	O	O	O	O
hearing	hearing	O	DISEASE	OTHERS	I
impairment	impairment	O	DISEASE	OTHERS	I
.	.	O	O	O	O

